Bristol-Myers Escapes Abilify Movement Disorder Suit

Law360, New York (December 5, 2013, 6:13 PM EST) -- A Pennsylvania federal judge on Monday dismissed a man's lawsuit against Bristol-Myers Squibb Co. over a movement disorder he developed after taking the drug Abilify, saying that drugmakers are not required to provide detailed instructions to physicians about monitoring for adverse reactions.

Plaintiff Ryan Bergstresser claimed that Bristol-Myers failed to provide information in Abilify's package insert about monitoring for dystonia, a muscular disease marked by involuntary muscle contractions. Bergstresser allegedly suffers from permanent dystonia caused by Abilify he took to treat his depression.

U.S. District Judge...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Bergstresser v. Bristol-Meyers Squibb Company


Case Number

3:12-cv-01464

Court

Pennsylvania Middle

Nature of Suit

Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability

Judge

Malachy E Mannion

Date Filed

July 30, 2012

Law Firms

Companies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.